Susvimo (ophthalmic)

Ranibizumab is used in adults to treat specific eye issues. It can be given as an injection or as an eye implant.

Ranibizumab may be used to treat wet age-related macular degeneration, swelling in the retina, eye issues caused by diabetes, or nearsightedness due to abnormal blood vessel growth in the eye.

The eye implant is only for certain eye problems in people who have already responded to similar eye injections.

Ranibizumab may also be used for purposes not mentioned in this medication guide.

You should not receive ranibizumab if you have swelling, redness, pain inside your eyes, or any type of infection in or around your eyes.

Call your doctor at once if you have sudden vision problems, eye pain, redness, discharge, or watering in your eye, or if your eyes are more sensitive to light.

You should not receive ranibizumab if you are allergic to it, or if you have:

• swelling, redness, or pain inside or around your eyes; or
• any type of infection in or around your eyes.

Tell your doctor if you have or have ever had:

• an eye infection;
• retinal detachment;
• a heart attack or stroke;
• glaucoma or another condition that increases pressure inside your eyes; or
• taken certain other medicines that can increase bleeding risk, such as warfarin, aspirin, or nonsteroidal anti-inflammatory drugs (NSAID).

It is not known if ranibizumab will harm an unborn baby. Use effective birth control while using ranibizumab and for at least 12 months after your last dose. Tell your doctor if you are pregnant or plan to become pregnant.

Ask a doctor if it is safe to breastfeed while using this medicine.

Get emergency medical help if you have signs of an allergic reaction: hives, difficulty breathing, swelling of your face, lips, tongue, or throat.

Susvimo may cause serious side effects. Call your doctor right away if you have:

• increased eye pain, swelling, or redness in your eye;
• vision loss with or without pain, sensitivity to light;
• blurred vision, seeing halos around lights;
• feeling like something is in your eye;
• discharge or watery eyes;
• sudden changes in your vision, seeing flashes of light, spots or shadows; or
• a "spider web" appearance in your vision.

Common side effects of Susvimo may include:

• eye pain;
• sensitivity to light;
• "floaters" in your vision;
• increased pressure inside the eye; or
• eye redness or a blood spot on the white of your eye.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Follow all directions on your prescription label and read all medication guides or instruction sheets.

Ranibizumab injection is administered as an injection into the eye. Your doctor will use a medicine to numb your eye before giving you the injection. You will receive this injection in your doctor's office or other clinical setting.

Ranibizumab eye implant is placed through the white part of the eye by your healthcare provider. Your implant may be refilled about every 6 to 9 months, depending on the condition being treated.

Tell your doctor that you have a ranibizumab eye implant before having an MRI or any procedure on your eye.

Your eyes will be checked to make sure ranibizumab has not caused any serious side effects.

Call your doctor right away if you notice the eye implant has moved out of place.

Wash your hands first if you have to rub your eyes or touch the area where the eye implant is located.

Call your doctor for instructions if you miss an appointment for your ranibizumab injection.

In a medical setting, an overdose would be treated quickly.

Avoid driving or doing anything dangerous until the eye shield can be taken off and you can see clearly.

Medicine used in the eyes is unlikely to be affected by other drugs you take. However, many drugs can interact with each other. Inform your doctor about all the medicines you are currently using, including prescription and over-the-counter medicines, vitamins, and herbal products.

Find detailed information on biosimilars for this medication.